Tenaya Therapeutics
TNYA
64 hedge funds and large institutions have $128M invested in Tenaya Therapeutics in 2023 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 15 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 12
35% more capital invested
Capital invested by funds: $94.7M → $128M (+$33.6M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
6% less funds holding
Funds holding: 68 → 64 (-4)
6.36% less ownership
Funds ownership: 73.64% → 67.28% (-6.4%)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
69% less call options, than puts
Call options by funds: $70K | Put options by funds: $224K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$2.61M |
| 2 |
BlackRock
New York
|
+$1.47M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$885K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$706K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$351K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$4.94M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.08M |
| 3 |
ROTUOC
Regents of the University of California
Oakland,
California
|
-$1.87M |
| 4 |
Blackstone Inc
New York
|
-$643K |
| 5 |
Walleye Capital
New York
|
-$410K |
TNYA Hedge Fund Activity: Q1 2023 in Review
64 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Tenaya Therapeutics (TNYA) for Q1 2023, worth a combined $128M — up 35% from $94.7M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of TNYA and 11 opened new positions — a net loss of 4 holders — while 12 trimmed existing stakes and 27 added.
The largest buyer was Fidelity Investments, adding an estimated $2.61M. The largest seller was RTW Investments, exiting entirely with an estimated $4.94M sold.
- 64 institutional investors held Tenaya Therapeutics (TNYA) as of Q1 2023, down from 68 in Q4 2022.
- Funds reported $128M of Tenaya Therapeutics stock for Q1 2023, up 35% quarter-over-quarter.
- 11 funds opened new Tenaya Therapeutics positions in Q1 2023 and 15 closed out, a net change of -4 holders.
- The largest Tenaya Therapeutics buyer in Q1 2023 was Fidelity Investments, an estimated $2.61M added.
- The largest Tenaya Therapeutics seller in Q1 2023 was RTW Investments, an estimated $4.94M sold.
Based on aggregated 13F filings for Q1 2023.